Dr. Steve Cutler, CEO and Mr. Brendan Brennan, CFO of ICON plc, will present
Dublin, Ireland, 3 September 2019 – ICON plc, (NASDAQ: ICLR) a global provider of drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical device industries, today announced that Dr. Steve Cutler, CEO and Mr. Brendan Brennan, CFO of ICON plc, will present at Baird’s 2019 Global Healthcare Conference on Thursday, September 5, 2019. The presentation will be webcast live from 1.25pm EDT.
A live webcast will be available via the Investor section of our website under “Events”.
About ICON plc
ICON plc is a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries. The company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. With headquarters in Dublin, Ireland, ICON employed approximately 14,400 employees in 98 locations in 40 countries as at June 30, 2019. Further information is available at www.iconplc.com.
Source: ICON plc
Contact: Investor Relations +1888 381 7923 or
Jonathan Curtain Vice President Corporate Finance and Investor Relations +353 1 291 2000